Form 4: Charles River Laboratories International CFO Buys Shares
Insider Transaction (Form 4)
Glenn Coleman, EVP & Chief Financial Officer of Charles River Laboratories International, Inc., purchased 10 shares of common stock on September 30, 2026 for $297.43 per share.
Summary
- Open-market purchase: acquired 10 Common Stock at $297.43 ($2,974) on September 30, 2026; holds 27,762 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $2,974, committing personal capital to the stock.
Insider Transactions
Glenn Coleman — Officer (EVP & Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Open-market purchase | Common Stock | 10 | $297 | $3.0K | 27,762 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Open-market purchase (10 shares) |
Keywords
insider transaction, Form 4, CRL, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., bullish, Glenn Coleman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.